The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice

被引：47

作者：

Kuo, Frank C. ^{[1
,2
,3
]}

Mar, Brenton G. ^{[2
,4
,5
]}

Lindsley, R. Coleman ^{[6
,7
]}

Lindeman, Neal I. ^{[1
,2
,3
]}

机构：

[1] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA

[2] Dana Farber Canc Inst, Boston, MA 02115 USA

[3] Harvard Med Sch, Dept Pathol, Boston, MA USA

[4] Boston Childrens Hosp, Dept Pediat Oncol, Boston, MA USA

[5] Harvard Med Sch, Dept Pediat, Boston, MA USA

[6] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[7] Harvard Med Sch, Dept Med, Boston, MA USA

来源：

BLOOD | 2017年 / 130卷 / 04期

关键词：

INTERNAL TANDEM DUPLICATION; ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; IDENTIFIES RECURRENT MUTATIONS; SOMATIC MUTATIONS; RETROSPECTIVE ANALYSIS; CLONAL HEMATOPOIESIS; IKZF1; DELETION; IMPACT; RISK;

D O I：

10.1182/blood-2017-03-734533

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Advances in technology that have transpired over the past 2 decades have enabled the analysis of cancer samples for genomic alterations to understand their biologic function and to translate that knowledge into clinical practice. With the power to analyze entire genomes in a clinically relevant time frame and with manageable costs comes the question of whether we ought to and when. This review focuses on the relative merits of 3 approaches to molecular diagnostics in hematologic malignancies: indication-specific single gene assays, gene panel assays that test for genes selected for their roles in cancer, and genome-wide assays that broadly analyze the tumor exomes or genomes. After addressing these in general terms, we review specific use cases in myeloid and lymphoid malignancies to highlight the utility of single gene testing and/or larger panels.

引用

页码：433 / 439

页数：7

共 85 条

[61] Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing [J].

Richter, Julia ;

Schlesner, Matthias ;

Hoffmann, Steve ;

Kreuz, Markus ;

Leich, Ellen ;

Burkhardt, Birgit ;

Rosolowski, Maciej ;

Ammerpohl, Ole ;

Wagener, Rabea ;

Bernhart, Stephan H. ;

Lenze, Dido ;

Szczepanowski, Monika ;

Paulsen, Maren ;

Lipinski, Simone ;

Russell, Robert B. ;

Adam-Klages, Sabine ;

Apic, Gordana ;

Claviez, Alexander ;

Hasenclever, Dirk ;

Hovestadt, Volker ;

Hornig, Nadine ;

Korbel, Jan O. ;

Kube, Dieter ;

Langenberger, David ;

Lawerenz, Chris ;

Lisfeld, Jasmin ;

Meyer, Katharina ;

Picelli, Simone ;

Pischimarov, Jordan ;

Radlwimmer, Bernhard ;

Rausch, Tobias ;

Rohde, Marius ;

Schilhabel, Markus ;

Scholtysik, Rene ;

Spang, Rainer ;

Trautmann, Heiko ;

Zenz, Thorsten ;

Borkhardt, Arndt ;

Drexler, Hans G. ;

Moeller, Peter ;

MacLeod, Roderick A. F. ;

Pott, Christiane ;

Schreiber, Stefan ;

Truemper, Lorenz ;

Loeffler, Markus ;

Stadler, Peter F. ;

Lichter, Peter ;

Eils, Roland ;

Kueppers, Ralf ;

Hummel, Michael .

NATURE GENETICS, 2012, 44 (12) :1316-1320

[62] Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia [J].

Roberts, K. G. ;

Li, Y. ;

Payne-Turner, D. ;

Harvey, R. C. ;

Yang, Y-L. ;

Pei, D. ;

McCastlain, K. ;

Ding, L. ;

Lu, C. ;

Song, G. ;

Ma, J. ;

Becksfort, J. ;

Rusch, M. ;

Chen, S-C. ;

Easton, J. ;

Cheng, J. ;

Boggs, K. ;

Santiago-Morales, N. ;

Iacobucci, I. ;

Fulton, R. S. ;

Wen, J. ;

Valentine, M. ;

Cheng, C. ;

Paugh, S. W. ;

Devidas, M. ;

Chen, I-M. ;

Reshmi, S. ;

Smith, A. ;

Hedlund, E. ;

Gupta, P. ;

Nagahawatte, P. ;

Wu, G. ;

Chen, X. ;

Yergeau, D. ;

Vadodaria, B. ;

Mulder, H. ;

Winick, N. J. ;

Larsen, E. C. ;

Carroll, W. L. ;

Heerema, N. A. ;

Carroll, A. J. ;

Grayson, G. ;

Tasian, S. K. ;

Moore, A. S. ;

Keller, F. ;

Frei-Jones, M. ;

Whitlock, J. A. ;

Raetz, E. A. ;

White, D. L. ;

Hughes, T. P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) :1005-1015

[63] Genomics in acute lymphoblastic leukaemia: insights and treatment implications [J].

Roberts, Kathryn G. ;

Mullighan, Charles G. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (06) :344-357

[64] Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia [J].

Rossi, Davide ;

Rasi, Silvia ;

Fabbri, Giulia ;

Spina, Valeria ;

Fangazio, Marco ;

Forconi, Francesco ;

Marasca, Roberto ;

Laurenti, Luca ;

Bruscaggin, Alessio ;

Cerri, Michaela ;

Monti, Sara ;

Cresta, Stefania ;

Fama, Rosella ;

De Paoli, Lorenzo ;

Bulian, Pietro ;

Gattei, Valter ;

Guarini, Anna ;

Deaglio, Silvia ;

Capello, Daniela ;

Rabadan, Raul ;

Pasqualucci, Laura ;

Dalla-Favera, Riccardo ;

Foa, Robin ;

Gaidano, Gianluca .

BLOOD, 2012, 119 (02) :521-529

[65] ITD assembler: an algorithm for internal tandem duplication discovery from short-read sequencing data [J].

Rustagi, Navin ;

Hampton, Oliver A. ;

Li, Jie ;

Xi, Liu ;

Gibbs, Richard A. ;

Plon, Sharon E. ;

Kimmel, Marek ;

Wheeler, David A. .

BMC BIOINFORMATICS, 2016, 17

[66] ENZYMATIC AMPLIFICATION OF BETA-GLOBIN GENOMIC SEQUENCES AND RESTRICTION SITE ANALYSIS FOR DIAGNOSIS OF SICKLE-CELL ANEMIA [J].

SAIKI, RK ;

SCHARF, S ;

FALOONA, F ;

MULLIS, KB ;

HORN, GT ;

ERLICH, HA ;

ARNHEIM, N .

SCIENCE, 1985, 230 (4732) :1350-1354

[67] Somatic RHOA mutation in angioimmunoblastic T cell lymphoma [J].

Sakata-Yanagimoto, Mamiko ;

Enami, Terukazu ;

Yoshida, Kenichi ;

Shiraishi, Yuichi ;

Ishii, Ryohei ;

Miyake, Yasuyuki ;

Muto, Hideharu ;

Tsuyama, Naoko ;

Sato-Otsubo, Aiko ;

Okuno, Yusuke ;

Sakata, Seiji ;

Kamada, Yuhei ;

Nakamoto-Matsubara, Rie ;

Nguyen Bich Tran ;

Izutsu, Koji ;

Sato, Yusuke ;

Ohta, Yasunori ;

Furuta, Junichi ;

Shimizu, Seiichi ;

Komeno, Takuya ;

Sato, Yuji ;

Ito, Takayoshi ;

Noguchi, Masayuki ;

Noguchi, Emiko ;

Sanada, Masashi ;

Chiba, Kenichi ;

Tanaka, Hiroko ;

Suzukawa, Kazumi ;

Nanmoku, Toru ;

Hasegawa, Yuichi ;

Nureki, Osamu ;

Miyano, Satoru ;

Nakamura, Naoya ;

Takeuchi, Kengo ;

Ogawa, Seishi ;

Chiba, Shigeru .

NATURE GENETICS, 2014, 46 (02) :171-+

[68] The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype [J].

Schneider, Friederike ;

Hoster, Eva ;

Unterhalt, Michael ;

Schneider, Stephanie ;

Dufour, Annika ;

Benthaus, Tobias ;

Mellert, Gudrun ;

Zellmeier, Evelyn ;

Kakadia, Purvi M. ;

Bohlander, Stefan K. ;

Feuring-Buske, Michaela ;

Buske, Christian ;

Braess, Jan ;

Heinecke, Achim ;

Sauerland, Maria C. ;

Berdel, Wolfgang E. ;

Buechner, Thomas ;

Woermann, Bernhard J. ;

Hiddemann, Wolfgang ;

Spiekermann, Karsten .

BLOOD, 2012, 119 (19) :4383-4386

[69] Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology [J].

Sheikine, Yuri ;

Kuo, Frank C. ;

Lindeman, Neal I. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (09) :929-933

[70] Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: By the GIMEMA working party on chronic myeloid leukemia [J].

Soverini, Simona ;

Colarossi, Sabrina ;

Gnani, Alessandra ;

Rosti, Gianantonio ;

Castagnetti, Fausto ;

Poerio, Angela ;

Iacobucci, Ilaria ;

Amabile, Marilina ;

Abruzzese, Elisabetta ;

Orlandi, Ester ;

Radaelli, Franca ;

Ciccone, Fabrizio ;

Tiribelli, Mario ;

di Lorenzo, Roberto ;

Caracciolo, Clementina ;

Izzo, Barbara ;

Pane, Fabrizio ;

Saglio, Giuseppe ;

Baccarani, Michele ;

Martinelli, Giovanni .

CLINICAL CANCER RESEARCH, 2006, 12 (24) :7374-7379

← 1 2 3 4 5 6 7 8 9 →